|Day Low/High||61.86 / 62.73|
|52 Wk Low/High||47.97 / 64.00|
The Merck Foundation and YMCA of the USA (Y-USA) announced today that the Merck Foundation has provided a grant of $2 million over three years to support efforts to expand the YMCA's Diabetes Prevention Program (YMCA's DPP).
MSD Animal Health (known as Merck Animal Health in the United States and Canada) is proud to announce a landmark accomplishment in its fight against rabies with the donation of now more than two million doses of its...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that extensive data on KEYTRUDA ® (pembrolizumab), the company's anti-PD-1 therapy, have been accepted for presentation at the...
A series of clinical trials will test the combination of Bristol-Myers Squibb's Opdivo with Nektar's NKTR-214 in multiple tumor types.
Stocks end Monday's session sharply lower as Wall Street grows restless ahead of the first presidential debate.
Stocks hold near session lows by mid-afternoon Monday as Wall Street grows restless ahead of the first presidential debate.
Stocks are lower Monday as Wall Street's attention shifts to the looming presidential debate from central bank policy.
Rumors are swirling about Big Pharma interest in the cancer drug developer, but the validity of such theories is questioned by at least some company followers.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2016 sales and earnings conference call with institutional investors and analysts at 8:00 a.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.
These dividend stocks are poised to increase their payouts to shareholders soon.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, will host a teleconference for investors following the presentation of data at the European Society for Medical Oncology (ESMO) 2016 Congress in...
Allegations that Merck breached patents on diabetes blockbuster Lantus looks like a replay of Sanofi's 2015 case against Eli Lilly.
U.S. stock futures point higher as oil prices rally; Canada's autoworkers' union and GM make little progress in contract talks ahead of a Monday deadline.
Merck (MRK) and Pfizer's (PFE) diabetes treatment met its primary endpoint in a Phase III trial.
Drug companies like Merck, Pfizer and Johnson & Johnson are spending big bucks on the opposition of Proposition 61.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today issued its 2015/2016 global corporate responsibility report.
Zoetis is selling a lineup of drugs for dogs, and that looks to mean big business.
Zoetis is not averse to a little noise as investors, analysts take notice.
From Altria to Western Union, these 21 companies have must-own dates over the next week.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C.
Merck's (MRK) lung cancer drug, called Keytruda, was given breakthrough therapy status by the FDA.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.
Merck has decided to discontinue the development of its osteoporosis drug and will not seek regulatory approval for its use.
Merck (MRK) will no longer develop its osteoporosis treatment due to an increased risk of stroke.